Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-18

Clinical Trial Update: Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating midodrine plus albumin for cirrhosis with functional renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin
  • Midodrine (Midodrine)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Cirrhosis, Renal Failure | Phase 2 | Status: COMPLETED